9475301000001104: FemSeven Sequi Phase 2 (product)

SNOMED CT Concept\Pharmaceutical / biologic product\UK product\Trade family\FemSeven Sequi Phase 2

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

48229101000001116 FemSeven Sequi Phase 2 (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

48229201000001111 FemSeven Sequi Phase 2 en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
FemSeven Sequi Phase 2	Is a	Trade family	true	Inferred relationship	Existential restriction modifier
FemSeven Sequi Phase 2	Has trade family group	FemSeven	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
FemSeven Sequi Phase 2 patches (Pilsco Ltd)	Is a	True	FemSeven Sequi Phase 2	Inferred relationship	Existential restriction modifier
FemSeven Sequi Phase 2 patches (CST Pharma Ltd)	Is a	True	FemSeven Sequi Phase 2	Inferred relationship	Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd)	Is a	True	FemSeven Sequi Phase 2	Inferred relationship	Existential restriction modifier
FemSeven Sequi Phase 2 patches (Lexon (UK) Ltd)	Is a	True	FemSeven Sequi Phase 2	Inferred relationship	Existential restriction modifier
FemSeven Sequi Phase 2 patches (Mawdsley-Brooks & Company Ltd)	Is a	True	FemSeven Sequi Phase 2	Inferred relationship	Existential restriction modifier
FemSeven Sequi Phase 2 patches (Waymade Healthcare Plc)	Is a	True	FemSeven Sequi Phase 2	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets